A unified platform for the rapid assembly of glutarimides for Cereblon E3 ligase modulatory drugs

David M Whalley1, Olivier Lorthioir2, Niall A Anderson3

  • 1Oncology R&D, The Discovery Centre, AstraZeneca, Cambridge, UK. david.whalley2@astrazeneca.com.

Nature Communications
|June 21, 2026
PubMed

Related Concept Videos